Related Topics
Clear communication key to fostering trust in COVID-19 guidance
Harvard Chan School's Jay Winsten offers a critique of recent communications about COVID-19 boosters, as well as advice on how health officials can improve their messaging.
Kizzmekia Corbett is just getting started
She played a key role in developing the Moderna COVID-19 vaccine. Now at the Harvard Chan School, she’s turning to the pathogens that may spark the next pandemic.
Finding community in Boston Vaccine Day
September 23, 2021—Keona Wynne wasn’t sure if people were going to show up. For months, she and a team of volunteers had worked in their spare time—weekends and nights, between work meetings and classes—to organize Boston Vaccine Day,…
Understanding the new recommendations on COVID-19 boosters
In this Q&A, Eric Rubin discusses the FDA advisory panel vote on recommendations for COVID-19 boosters.
Vaccinating in conflict zones
Hammering out temporary ceasefires in conflict zones will be necessary to vaccinate enough people against COVID-19 so that the pandemic can be brought to an end, according to humanitarian professionals.
A global health ‘conductor’ returns to Harvard Chan School
Muhammad Pate, a former Nigerian health minister, plans to explore trends that will shape the future of global health, and share his perspective as a practitioner September 1, 2021—When Muhammad Pate became head of Nigeria’s National Primary Health…
What will it be like when COVID-19 becomes endemic?
In a Q&A, Yonatan Grad, Melvin J. and Geraldine L. Glimcher Associate Professor of Immunology and Infectious Diseases, discusses what endemic COVID-19 will look like.
Why mandates are needed in the COVID-19 ‘playbook’
As the Delta variant propels COVID-19 infections across the U.S., Rebecca Weintraub says it’s important to make it easier for people to get vaccines, to answer questions from those who are hesitant about getting inoculated—and to have vaccine…
Why ‘breakthrough’ COVID-19 cases happen
In spite of strongly protective vaccines, some “breakthrough” COVID-19 infections are to be expected because no vaccine is 100% effective.
Vaccine push slows COVID deaths among Brazil’s elderly
Early efforts to vaccinate elderly people in Brazil against COVID-19 appear to be preventing deaths, according to new research. The study, co-authored by Marcia Castro, Andelot Professor of Demography and chair of the Department of Global Health and…